Phenylketonuria Pku clinical trials

Explore recruiting phenylketonuria pku clinical trials.

Recruiting phenylketonuria pku studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Phenylketonuria Pku trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3 Multi-Center Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase in Adolescent Subjects (Ages 12-17) with Phenylketonuria Featuring an Open-Label Randomized Two-Arm (Active vs Diet-Only Control) Design

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Treated With Sepiapterin (EPIPHENY)

Ireland, Sweden, Poland, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1/2, First-in-Human, Open-Label, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of mRNA 3210 in Participants with Phenylketonuria

France, Spain, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 3, Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of SYNB1934 in Patients with PKU (SYNPHENY-3)

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Crossover, Open-Label, Active-Controlled Study of Sepiapterin versus Sapropterin in Participants With Phenylketonuria ≥2 years of Age

Denmark, Spain, Italy, France, Germany, Slovenia +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria

Netherlands, Germany, Spain, Italy, Denmark, Portugal +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phenylketonuria Pku trials by city

Phenylketonuria Pku in Toronto Phenylketonuria Pku in Vancouver Phenylketonuria Pku in Montreal Phenylketonuria Pku in Calgary Phenylketonuria Pku in Edmonton Phenylketonuria Pku in Ottawa Phenylketonuria Pku in Winnipeg Phenylketonuria Pku in Quebec City Phenylketonuria Pku in Hamilton Phenylketonuria Pku in Kitchener Phenylketonuria Pku in London Phenylketonuria Pku in Halifax Phenylketonuria Pku in New York Phenylketonuria Pku in Los Angeles Phenylketonuria Pku in Chicago Phenylketonuria Pku in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease